BioNTech SE - ADR vs Global X Defense Tech ETF — how do they compare? BioNTech SE - ADR trades at $92.8 (market cap $23.31B), while Global X Defense Tech ETF trades at $69.94. The key difference: Global X Defense Tech ETF is trading nearer its 52-week high, BioNTech SE - ADR nearer its low. Which is the better fit depends on your goals.
| BNTX | SHLD | |
|---|---|---|
Market Cap | $23.31B | — |
Sector | Health | Sector/Thematic |
52-Week High | $119.34 | $78.02 |
52-Week Low | $83.89 | $58.20 |
Enterprise Value | $6.60B | — |
Trailing returns across standard periods
BioNTech is a Germany-based biotechnology company that focuses on developing cancer therapeutics, including individualized immunotherapy, as well as vaccines for infectious diseases, including COVID-19. The company's oncology pipeline contains several classes of drugs, including mRNA-based drugs to encode antigens, neoantigens, cytokines, and antibodies.
Read more on BNTX →SHLD tracks the Global X Defense Tech Index, targeting companies that lead the technological transformation of the defense sector. It focuses on pure-play innovators in cybersecurity, artificial intelligence, robotics, and advanced military systems, excluding traditional commercial aerospace to maintain a high level of thematic purity.
Read more on SHLD →